SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-17-032433
Filing Date
2017-02-07
Accepted
2017-02-07 06:11:32
Documents
1
Group Members
SV LIFE SCIENCES FUND V (GP), L.P.SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.SV LIFE SCIENCES FUND V, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d335663dsc13da.htm SC 13D/A 90307
  Complete submission text file 0001193125-17-032433.txt   92078
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Subject) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88910 | Film No.: 17577153
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SV LIFE SCIENCES ADVISERS, LLC ONE BOSTON PLACE, SUITE 3900 BOSTON MA 02108
Business Address C/O SV LIFE SCIENCES ADVISERS, LLC ONE BOSTON PLACE, SUITE 3900 BOSTON MA 02108 617-367-8100
SVLSF V, LLC (Filed by) CIK: 0001644160 (see all company filings)

IRS No.: 264430055 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A